Ohio regulator orders
insurers, benefit managers to give lowest drug price
Send a link to a friend
[April 05, 2018] By
Caroline Humer
(Reuters) - The Ohio Department of
Insurance said on Wednesday that pharmacy benefit managers and insurers
would have to disclose the lowest price for a prescription drug for Ohio
consumers, part of a move to prevent insured consumers potentially
paying more than those without insurance.
|
Two of the largest pharmacy benefit managers, Express Scripts
Holding Co. and CVS Health Inc said their contracts include clauses
by which members receive the lowest cost automatically.
"We do not engage in this anti-consumer practice and are working
constructively with state and federal policymakers to ban the
practice," Express Scripts spokesman Phil Blando said in a
statement.
U.S. lawmakers introduced legislation last month called the "Patient
Right to Know Drug Prices Act" and the "Know the Lowest Price Act of
2018", both aimed at preventing companies from instituting so called
"gag clauses" in contracts.
The agency said it would ban the practice in which some insurers and
pharmacy benefit managers use contractual provisions to prevent
pharmacists from discussing with consumers if low-cost options are
available for prescriptions, effective immediately.
[to top of second column] |
It would also prohibit them from charging customers a higher amount
for prescription drugs than what it would otherwise cost without
insurance coverage.
CVS last month said in a statement after those bills were introduced
that its pharmacy benefit members always get the benefit of the
lower price.
"If a CVS Caremark plan member's copay for a drug is greater than
the dispensing pharmacy's contracted rate, it is not our practice to
collect that difference from the pharmacy," it said.
OptumRx, the pharmacy benefit division of UnitedHealth Group Inc was
not immediately available for comment.
(Reporting by Caroline Humer in New York and Arjun Panchadar in
Bengaluru; Editing by Susan Thomas)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |